Paul Tudor Jones II acquired 38 Thousand Coherus Biosciences shares worth $79.3 Thousand. That's 0.00% of their equity portfolio (1336th largest holding). The first Coherus Biosciences trade was made in Q2 2016. Since then Paul Tudor Jones II bought shares ten more times and sold shares on nine occasions. The investor's estimated purchase price is $605 Thousand, resulting in a loss of 87%.